Open access
Open access
Powered by Google Translator Translator

Endocrinology (all articles)

Crossover RCT | Preliminary study showed closed-loop insulin delivery might improve glycemic control in some adults with Type 2 DM

15 Jan, 2023 | 19:56h | UTC

Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial – Nature Medicine

News Release: Artificial pancreas successfully trialed for use by type 2 diabetes patients – University of Cambridge

Commentary: Artificial Pancreas Device May Help Folks With Type 2 Diabetes – HealthDay

 


Report | Obstacles and opportunities in managing coexisting obesity and CKD

13 Jan, 2023 | 13:30h | UTC

Obstacles and Opportunities in Managing Coexisting Obesity and CKD: Report of a Scientific Workshop Cosponsored by the National Kidney Foundation and The Obesity Society – American Journal of Kidney Diseases

 


M-A | Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy effects on obesity comorbidities

12 Jan, 2023 | 13:00h | UTC

Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy effects on obesity comorbidities: A systematic review and meta-analysis – Frontiers in Surgery

 


M-A | Blood endotoxin levels as biomarker of non-alcoholic fatty liver disease

12 Jan, 2023 | 12:57h | UTC

Blood endotoxin levels as biomarker of non-alcoholic fatty liver disease: a systematic review and meta-analysis – Clinical Gastroenterology and Hepatology

 


M-A | The prevalence of obesity among children with type 2 DM

12 Jan, 2023 | 12:53h | UTC

The Prevalence of Obesity Among Children With Type 2 Diabetes: A Systematic Review and Meta-analysis – JAMA Network Open

Commentary: Not All Pediatric Cases of Type 2 Diabetes Have Obesity – HealthDay

 

Commentary on Twitter

 


NICE Guideline | Thyroid cancer: assessment and management

11 Jan, 2023 | 14:34h | UTC

Thyroid cancer: assessment and management – National Institute for Health and Care Excellence

 


Guideline Synopsis | Diabetes management in chronic kidney disease

10 Jan, 2023 | 14:52h | UTC

Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update – Annals of Internal Medicine

News Release: Group summarizes new guidelines for treating patients with diabetes and chronic kidney disease – American College of Physicians

Commentary: Layered Approach Recommended for Patients With Diabetes, CKD – HealthDay

Original Guideline: KDIGO 2022 Clinical practice guideline for diabetes management in chronic kidney disease.

 


AAP Guideline | Evaluation and treatment of children and adolescents with obesity

10 Jan, 2023 | 14:54h | UTC

Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity – Pediatrics

Executive Summary: Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity – Pediatrics

News Release: American Academy of Pediatrics Issues Its First Comprehensive Guideline on Evaluating, Treating Children and Adolescents With Obesity – American Academy of Pediatrics

Commentaries:

Childhood obesity requires early, aggressive treatment, new guidelines say – NPR

New guidance: Use drugs, surgery early for obesity in kids – Associated Press

 


Diagnostic accuracy study | Home waking salivary cortisone to screen for adrenal insufficiency

10 Jan, 2023 | 14:47h | UTC

Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency – NEJM Evidence

Commentary: At-home saliva test to diagnose adrenal insufficiency makes a difference to patients’ health – News Medical

 

Commentary on Twitter

 


Restoring mortality data in the FOURIER trial of evolocumab in patients with CVD: a reanalysis based on regulatory data

10 Jan, 2023 | 14:49h | UTC

Restoring mortality data in the FOURIER cardiovascular outcomes trial of evolocumab in patients with cardiovascular disease: a reanalysis based on regulatory data – BMJ Open

Commentaries: 

Yet Another Story on Re-Analyzing a Major Trial – Sensible Medicine

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees – TCTMD

Experts Issue Caution for Evolocumab Following New Review of FOURIER Data; Amgen Disputes the Claims – AJMC

 


Podcast | Endocrine emergencies

10 Jan, 2023 | 14:32h | UTC

#372 Endocrine Emergencies featuring Dr. Sara Markley Webster – The Curbsiders

 


ACP Guideline | Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults

9 Jan, 2023 | 14:59h | UTC

Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians – Annals of Internal Medicine

See also: Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians – Annals of Internal Medicine

News Release: American College of Physicians recommends bisphosphonates for initial treatment for osteoporosis in males and postmenopausal females diagnosed with primary osteoporosis

Summary for Patients: Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults

 


Guideline | Treatment of hypercalcemia of malignancy in adults

9 Jan, 2023 | 14:46h | UTC

Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline – The Journal of Clinical Endocrinology & Metabolism

See also: A Systematic Review Supporting the Endocrine Society Clinical Practice Guideline on the Treatment of Hypercalcemia of Malignancy in Adults – The Journal of Clinical Endocrinology & Metabolism

News Release: Experts provide first framework for treating hypercalcemia of malignancy in adults – News Medical

 


The year in cardiovascular medicine 2022: the top 10 papers in dyslipidemias

9 Jan, 2023 | 14:26h | UTC

The year in cardiovascular medicine 2022: the top 10 papers in dyslipidaemias – European Heart Journal

 

Commentary on Twitter

 


WHO manual on sugar-sweetened beverage taxation policies to promote healthy diets.

16 Dec, 2022 | 13:52h | UTC

WHO manual on sugar-sweetened beverage taxation policies to promote healthy diets – World Health Organization

News Release: WHO calls on countries to tax sugar-sweetened beverages to save lives – World Health Organization

Related:

M-A: Outcomes following taxation of sugar-sweetened beverages.

Public Policies to Reduce Sugary Drink Consumption in Children and Adolescents – Pediatrics

Cutting back on sugar-sweetened beverages: What works? – Cochrane Library

Association of a Beverage Tax on Sugar-Sweetened and Artificially Sweetened Beverages With Changes in Beverage Prices and Sales at Chain Retailers in a Large Urban Setting – JAMA

Impact of sugar‐sweetened beverage taxes on purchases and dietary intake: Systematic review and meta‐analysis – Obesity Reviews

Association between tax on sugar sweetened beverages and soft drink consumption in adults in Mexico: open cohort longitudinal analysis of Health Workers Cohort Study – The BMJ

Potential impact on prevalence of obesity in the UK of a 20% price increase in high sugar snacks: modelling study – The BMJ

Changes in food purchases after the Chilean policies on food labelling, marketing, and sales in schools: a before and after study – The Lancet Planetary Health

Association of a Sweetened Beverage Tax With Soda Consumption in High School Students – JAMA Pediatrics

Sugar-sweetened beverage taxes: Lessons to date and the future of taxation – PLOS Medicine

Banning the promotion of soft drinks could be more effective than a sugar tax – The Conversation

Sugar tax: why health experts want it but politicians and industry are resisting – The Guardian

 

Commentary on Twitter

 


Cohort Study | Association of the triglyceride glucose index as a measure of insulin resistance with mortality and CVD

9 Jan, 2023 | 13:42h | UTC

Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study – The Lancet Health Longevity

Invited Commentary: The triglyceride glucose index and cardiovascular disease outcomes – The Lancet Health Longevity

 


RCT | Effect of an intermittent calorie-restricted diet on Type 2 DM remission.

16 Dec, 2022 | 13:43h | UTC

Effect of an Intermittent Calorie-restricted Diet on Type 2 Diabetes Remission: A Randomized Controlled Trial – The Journal of Clinical Endocrinology & Metabolism (link to abstract – $ for full-text)

Commentaries: 

Expert reaction to study looking at intermittent fasting and type 2 diabetes – Science Media Centre

Intermittent Fasting Can Achieve Remission in Type 2 Diabetes – HealthDay

 

Commentary on Twitter

 


Guideline | ADA 2023 Standards of Medical Care in Diabetes.

14 Dec, 2022 | 15:59h | UTC

Guideline Homepage: ADA 2023 Standards of Medical Care in Diabetes – American Diabetes Association

Introduction: Standards of Medical Care in Diabetes—2023

Summary of Revisions: Standards of Medical Care in Diabetes—2023

  1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes—2023
  2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023
  3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2023
  4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2023
  5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2023
  6. Glycemic Targets: Standards of Care in Diabetes—2023
  7. Diabetes Technology: Standards of Care in Diabetes2023
  8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes—2023
  9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023
  10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023
  11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2023
  12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2023
  13. Older Adults: Standards of Care in Diabetes—2023
  14. Children and Adolescents: Standards of Care in Diabetes—2023
  15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2023
  16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2023
  17. Diabetes Advocacy: Standards of Care in Diabetes—2023

 


RCT | A remotely delivered self-directed behavioral intervention resulted in little weight loss in adults with obesity.

16 Dec, 2022 | 13:38h | UTC

Effect of a Remotely Delivered Self-directed Behavioral Intervention on Body Weight and Physical Health Status Among Adults With Obesity: The D-ELITE Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: The Challenge of Defining the Optimal Lifestyle Weight Loss Intervention for Real-world Settings – JAMA (free for a limited period)

 

Commentary from the author on Twitter (thread – click for more)

https://twitter.com/KateHoerster/status/1602703023738064897

 


Consensus Statement | Continuous glucose monitoring and metrics for clinical trials.

15 Dec, 2022 | 13:42h | UTC

Continuous glucose monitoring and metrics for clinical trials: an international consensus statement – The Lancet Diabetes & Endocrinology (free registration required)

 

Commentary on Twitter

 


RCT | A calorie-unrestricted low-carbohydrate, high-fat diet resulted in short-term weight loss and better glycemic control.

14 Dec, 2022 | 15:08h | UTC

Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial – Annals of Internal Medicine (link to abstract – $ for full-text)

Commentary: Low-Carbohydrate, High-Fat Diet Beneficial in T2DM in Short Term – HealthDay

Summary for Patients: Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease – Annals of Internal Medicine

 

Commentary on Twitter

 


RCT | Small trial suggests butyrate may be effective in reducing pediatric obesity.

14 Dec, 2022 | 14:56h | UTC

Therapeutic Effects of Butyrate on Pediatric Obesity: A Randomized Clinical Trial – JAMA Network Open

 

Commentary on Twitter

 


Review | GLP-1 receptor agonists for the reduction of atherosclerotic cardiovascular risk in patients with Type 2 Diabetes.

13 Dec, 2022 | 14:29h | UTC

GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes – Circulation (free for a limited period)

 


Consensus Statement | Management of thyroid eye disease.

12 Dec, 2022 | 12:51h | UTC

Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and the European Thyroid Association

Commentary: Worldwide Consensus on Thyroid Eye Disease? What Is In a Name? – Thyroid

News Release: New Consensus Statement on Management of Thyroid Eye Disease Published by American Thyroid Association and European Thyroid Association

 


UEG position paper | Obesity and digestive health.

12 Dec, 2022 | 12:41h | UTC

UEG position paper: Obesity and digestive health – UEG Journal

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.